May's top stories: human cloning breakthrough, Ranbaxy's record fine
US scientists made a breakthrough in human cloning research, the first ever H7N9 avian influenza vaccine was developed, Ranbaxy Laboratories agreed to pay a record fine and the first human trials on synthetic blood were made possible in Scotland. Pha…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Influenza | Influenza Vaccine | Pharmaceuticals | Vaccines